Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Nice ! donated two Theralase® TLC-2400

<< Previous

Bullboard Posts

Next >>

Comment by cytochromeon Feb 12, 2024 10:09am

173 Views

Post# 35875330

RE:RE:RE:RE:RE:Nice ! donated two Theralase® TLC-2400

There are actually several trials for Parkinson's and other neurodegenerative diseases using photobiomodulation. For Parkinson's:https://clinicaltrials.gov/search?cond=Parkinsons%20Disease&term=photobiomodulation

Current hypotheses around the benefits are not from direct absorption of light but from indirect systenic effects mediated perhaps by mitochondria in the blood as well as absorption by immune and stem cells. Michael Hamblin talks a little about this here in a recent presentation he did in South Africa:https://www.youtube.com/watch?v=bPQo6HM_KrQ&ab_channel=BiofeedbackAssociationofSouthAfrica

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?